WEDNESDAY, Oct. 11, 2023 (HealthDay News) — A medication already approved for excessive daytime sleepiness may help ease attention-deficit/hyperactivity disorder (ADHD) symptoms in adults who aren’t getting relief from available treatments, according to a small pilot study. Solriamfetol is a nonstimulant drug that is approved for sleepiness caused by narcolepsyContinue Reading

MONDAY, Oct. 9, 2023 (HealthDay News) — Researchers have developed an antibody that can reduce Alzheimer’s-like brain damage in lab mice — inspired by the case of one woman with remarkable resistance to the disease. The work, by researchers at Mass General Brigham, Harvard Medical School in Boston, and elsewhere,Continue Reading

FRIDAY, Oct. 6, 2023 (HealthDay News) — Former pro football players with symptoms of depression or anxiety are far more likely to receive an unverifiable diagnosis of chronic traumatic encephalopathy (CTE) than players without those mental health conditions, a new study reports. Players with depression are 9.5 times more likelyContinue Reading

WEDNESDAY, Sept. 27, 2023 (HealthDay News) — A newer understanding of multiple sclerosis (MS) suggests that psychiatric conditions like anxiety and depression may emerge long before classic MS symptoms. “For a long time, it was thought that MS only really began clinically when a person experienced their first demyelinating event,Continue Reading

WEDNESDAY, Sept. 27, 2023 (HealthDay News) — Everyone’s seen a movie or TV show featuring someone sleepwalking — eyes half-lidded, bumbling around, tripping over furniture. But sleepwalkers are actually capable of much more complex behaviors during their restless slumber, a new paper says. During sleep some people can engage inContinue Reading